Latest Cyberonics Inc (CYBX) Headlines Insider Trading

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Cyberonics Inc (CYBX) Headlines

Insider Trading Alert - VRSN, TUP And CYBX Traded By Insiders
at The Street - Fri Mar 07, 10:00AM CST
Stocks with insider trader activity include VRSN, TUP and CYBX

Insider Trading Alert - IP, CYBX And JAZZ Traded By Insiders
at The Street - Thu Mar 06, 1:00PM CST
Stocks with insider trader activity include IP, CYBX and JAZZ

Cyberonics Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 2:10PM CST
On Feb 26, 2014, Zacks Investment Research upgraded Cyberonics Inc. to a Zacks Rank #2 (Buy).

Cyberonics Q3 sales short
at Investor's Business Daily - Thu Feb 20, 6:14PM CST
Implantable medical device maker Cyberonics (CYBX) said fiscal Q3 earnings per share rose 9% compared to a year ago, to 51 cents, beating analyst estimates by 2 cents. Revenue also rose 9% to $68.2 mil, just missing views for $69.7 mil. The company...

Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy®
PR Newswire - Thu Feb 20, 6:15AM CST
Cyberonics, Inc. (NASDAQ:CYBX) announced today the CE Mark (Conformité Européenne) approval in Europe for the AspireSR generator, the novel sixth-generation VNS Therapy generator.

Cyberonics Reports Fiscal 2014 Third Quarter Results
PR Newswire - Thu Feb 20, 6:00AM CST
Cyberonics, Inc. (NASDAQ:CYBX) today announced results for the quarter, and year-to-date, ended January 24, 2014.

Cyberonics To Participate In Upcoming Investor Conferences
PR Newswire - Wed Feb 19, 3:00PM CST
Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences.

Pacific Biosciences (PACB) Jumps: Stock Moves 8.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:46AM CST
Pacific Biosciences was a big mover last session, with shares rising over 8%.

Teleflex Recalls Tracheal Tube - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 1:50PM CST
Teleflex Medical has announced a worldwide voluntary recall of its ISIS HVT Tracheal Tube.

Neiman Marcus Launches Exclusive Lela Rose Tabletop Capsule Collection
PR Newswire - Thu Feb 13, 7:00AM CST
Today, Neiman Marcus announced the launch of a Lela Rose tabletop collection available exclusively at NeimanMarcus.com, marking the fashion designer's first collaboration in the home category.

Cepheid Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 2:20PM CST
On Feb 4, Zacks Investment Research downgraded Cepheid to a Zacks Rank #5 (Strong Sell).

The Zacks Analyst Blog Highlights:Henry Schein, Cyberonics, DexCom, Regeneron Pharmaceuticals and Bayer
PR Newswire - Tue Feb 11, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Henry Schein Inc. (Nasdaq:HSIC-Free Report), Cyberonics Inc. (Nasdaq:CYBX-Free Report), DexCom, Inc. (NasdaqXCM-Free Report), Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN-Free Report) and Bayer (OTC:BAYRY-Free Report).

Top 3 MedTech Stocks, Poised to Gain on Earnings - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 11:41AM CST
This hike is expected to result in 385 million new grant opportunities for researchers.

Insider Trading Alert - TER, CYBX, NSC, PLCM And MTW Traded By Insiders
at The Street - Mon Feb 10, 9:30AM CST
Stocks with insider trader activity include TER, CYBX, NSC, PLCM and MTW

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (strong buy) List for Friday

FDA Approval for DexCom's G4 PLATINUM - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 4:10PM CST
DexCom G4 PLATINUM gets FDA approval for use in children affected with diabetes aged between 2 and 17 years.

Natus Medical Upped to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 04, 2:00PM CST
On Jan 31, Zacks Investment Research upgraded Natus Medical to a Zacks Rank #1 (Strong Buy).

Cyberonics To Report Fiscal Year 2014 Third Quarter Results And Host Webcast And Conference Call On February 20, 2014
PR Newswire - Tue Feb 04, 8:00AM CST
Cyberonics, Inc. (NASDAQ:CYBX) today announced that the company will report financial results for the third quarter ended January 24, 2014, of its fiscal year ending April 25, 2014, on Thursday, February 20, 2014, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time).

The Future of Enterprise Communications from a Customer Perspective
PR Newswire - Thu Jan 30, 6:26AM CST
Reportlinker.com announces that a new market research report is available in its catalogue:

Leading Economic Indicator: U.S. Economic Recovery Likely To Continue Restrained Pace Throughout 2014
PR Newswire - Tue Jan 28, 8:06AM CST
The first Chemical Activity Barometer (CAB) reading of 2014 strengthened slightly, pointing to continued growth and an improving U.S. economy throughout 2014. The barometer in January ticked up to 94.0, increasing 0.2 points over December on a three-month moving average (3MMA) basis. This marks the ninth consecutive monthly gain for the CAB, which is now up 2.6 percent over a year ago. This growth is at a more moderate pace since the 0.4 percent gain last seen in September of 2013. The Chemical Activity Barometer is an established leading economic indicator, shown to lead U.S. business cycles by an average of eight months at cycle peaks, and four months at cycle troughs.

Cyberonics Inc. (CYBX) Stock Research Links

CYBX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 129

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 354

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 21

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 344

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 259

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 423

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 411

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 378

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 305

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading

Top 5 Most Recently Viewed Articles

Dollar Tree's Earnings Drop and Future Outlook Challenges

Updated Category News Views 123

Highlights from Dollar Tree's Earnings Report Dollar Tree has encountered significant challenges in the market after revealing that its second-quarter earnings did not meet analysts' expectations. The discount retailer reported a year-over-year decline in net income, attributing this downturn to the considerable difficulties posed by the current economic conditions. This...

Continue Reading
The Risks of Banking Standards: A Deep Dive into Safety

Updated Category News Views 411

Understanding Current Banking Risks Banks are integral to the economy, ensuring that funds flow smoothly throughout various sectors. However, recent decisions to relax standards for banks have raised significant concerns about potential risks that may arise. Weiss Ratings, a prominent name in independent bank safety evaluations, has recently highlighted unsettling changes...

Continue Reading
Koch and OCP Forge Ahead with New Joint Venture

Updated Category News Views 46

Tying Two Giants Together When industrial titans like Koch Ag & Energy Solutions and Moroccan powerhouse OCP decide to double down on their existing partnership, anyone with a stake in iron and fertilizer industries ought to take note. It's not every day that two behemoth corporations decide to lace up together in a joint venture, signaling a potential shift in market...

Continue Reading
Youlife Group Inc. Moves to Expand with Strategic Acquisitions

Updated Category News Views 213

Youlife Group Inc. Expands Market Reach with Key Acquisitions Youlife Group Inc. (NASDAQ: YOU), recognized as a leading provider of blue-collar lifetime services, has exciting plans to make strategic acquisitions aimed at bolstering its market position. This initiative comes as Youlife enters into non-binding term sheets with the controlling shareholders of four notable...

Continue Reading
Advancements in Wet AMD Treatment: Outlook Therapeutics Updates

Updated Category News Views 326

Significant Milestones for Outlook Therapeutics ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pioneering biopharmaceutical company, has made notable strides towards securing regulatory approval for its innovative treatment for wet age-related macular degeneration (wet AMD). Their investigational product, ONS-5010 (bevacizumab-vikg), is an ophthalmic...

Continue Reading